ripekg:evaluation/RIPEAD0800A4DFB9CD804 |
prov:wasInformedBy |
ripekg:evidence-aggregation/RIPEAD0800A4DFB9CD804 |
ripekg:evidence-aggregation/RIPEAD0800A4DFB9CD804 |
rdf:type |
rdfs:Resource |
ripekg:evidence-aggregation/RIPEAD0800A4DFB9CD804 |
rdf:type |
owl:Thing |
ripekg:evidence-aggregation/RIPEAD0800A4DFB9CD804 |
rdf:type |
ripe:EvidenceAggregationEvidence aggregation |
ripekg:evidence-aggregation/RIPEAD0800A4DFB9CD804 |
rdf:type |
tido:Activity |
ripekg:evidence-aggregation/RIPEAD0800A4DFB9CD804 |
prov:startedAtTime |
2025-10-31T15:38:25.019489Z |
ripekg:evidence-aggregation/RIPEAD0800A4DFB9CD804 |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI 1.0.0 |
ripekg:evidence-aggregation/RIPEAD0800A4DFB9CD804 |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI |
ripekg:evidence-aggregation/RIPEAD0800A4DFB9CD804 |
tido:contributesTo |
ripekg:research-integrity-assessment/RIPEAD0800A4DFB9CD804 |
ripekg:publication-details/RIPEAD0800A4DFB9CD804The optimal oral dose selection of ibandronate in Japanese patients with osteoporosis based on pharmacokinetic and pharmacodynamic properties |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAD0800A4DFB9CD804 |
ripekg:registry-evidence/RIPEAD0800A4DFB9CD804 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAD0800A4DFB9CD804 |
ripekg:study-design-evidence/RIPEAD0800A4DFB9CD804 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAD0800A4DFB9CD804 |